| Product Code: ETC8543960 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about non-24-hour sleep-wake disorder in the Netherlands |
4.2.2 Growing elderly population in the country |
4.2.3 Advancements in pharmaceutical research leading to the development of innovative drugs for the disorder |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new drugs in the Netherlands |
4.3.2 Limited market access for new entrants due to existing strong competition |
4.3.3 High costs associated with research and development for non-24-hour sleep-wake disorder drugs |
5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By Types |
6.1 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021- 2031F |
6.1.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hypernychthemeral Syndrome, 2021- 2031F |
6.1.5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Shift Work Disorder, 2021- 2031F |
6.1.6 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Jet Lag and Others, 2021- 2031F |
6.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Therapeutic Devices, 2021- 2031F |
6.2.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Nonbenzodiazepines, 2021- 2031F |
6.3.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.3.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.5.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Wellness Centers and Spa, 2021- 2031F |
6.5.6 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Import-Export Trade Statistics |
7.1 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Export to Major Countries |
7.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Imports from Major Countries |
8 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
8.1 Number of clinical trials conducted for non-24-hour sleep-wake disorder drugs in the Netherlands |
8.2 Patient adherence rate to prescribed medications for the disorder |
8.3 Percentage of healthcare professionals trained in diagnosing and treating non-24-hour sleep-wake disorder |
8.4 Rate of adoption of new treatment guidelines for the disorder |
8.5 Patient-reported outcomes on the effectiveness of medications for non-24-hour sleep-wake disorder |
9 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
9.1 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
10.1 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |